281 related articles for article (PubMed ID: 16201063)
1. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
Cottraux J; Bouvard MA; Milliery M
Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
[TBL] [Abstract][Full Text] [Related]
2. Combining Drug and Psychological Treatments for Obsessive- Compulsive Disorder: What is the Evidence, When and for Whom.
Albert U; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5632-5646. PubMed ID: 28707590
[TBL] [Abstract][Full Text] [Related]
3. Obsessive-compulsive disorder: strategies for using CBT and pharmacotherapy.
Storch EA; Merlo LJ
J Fam Pract; 2006 Apr; 55(4):329-33. PubMed ID: 16608672
[No Abstract] [Full Text] [Related]
4. Assessment and management of treatment-refractory obsessive-compulsive disorder in children.
Bloch MH; Storch EA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142
[TBL] [Abstract][Full Text] [Related]
5. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
Pediatric OCD Treatment Study (POTS) Team
JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
[TBL] [Abstract][Full Text] [Related]
6. Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial.
Franklin ME; Sapyta J; Freeman JB; Khanna M; Compton S; Almirall D; Moore P; Choate-Summers M; Garcia A; Edson AL; Foa EB; March JS
JAMA; 2011 Sep; 306(11):1224-32. PubMed ID: 21934055
[TBL] [Abstract][Full Text] [Related]
7. Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Tundo A; Salvati L; Busto G; Di Spigno D; Falcini R
J Clin Psychiatry; 2007 Oct; 68(10):1552-6. PubMed ID: 17960971
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of obsessive-compulsive disorder: drugs, psychotherapy or combined treatments?].
Albert U; Bogetto F
Riv Psichiatr; 2015; 50(4):153-4. PubMed ID: 26418594
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
[No Abstract] [Full Text] [Related]
10. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder.
Storch EA; Björgvinsson T; Riemann B; Lewin AB; Morales MJ; Murphy TK
Bull Menninger Clin; 2010; 74(2):167-85. PubMed ID: 20545494
[TBL] [Abstract][Full Text] [Related]
11. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis.
Ivarsson T; Skarphedinsson G; Kornør H; Axelsdottir B; Biedilæ S; Heyman I; Asbahr F; Thomsen PH; Fineberg N; March J;
Psychiatry Res; 2015 May; 227(1):93-103. PubMed ID: 25769521
[TBL] [Abstract][Full Text] [Related]
12. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis.
Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G
J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568
[TBL] [Abstract][Full Text] [Related]
13. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
[TBL] [Abstract][Full Text] [Related]
14. How resistant is 'treatment-resistant' obsessive-compulsive disorder in youth?
Krebs G; Isomura K; Lang K; Jassi A; Heyman I; Diamond H; Advani J; Turner C; Mataix-Cols D
Br J Clin Psychol; 2015 Mar; 54(1):63-75. PubMed ID: 25130442
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
[TBL] [Abstract][Full Text] [Related]
16. Commonly asked questions in the treatment of obsessive-compulsive disorder.
Arumugham SS; Reddy YC
Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy of obsessive-compulsive disorder and obsessive-compulsive spectrum disorders.
Denys D
Psychiatr Clin North Am; 2006 Jun; 29(2):553-84, xi. PubMed ID: 16650723
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcome for adolescent obsessive-compulsive disorder in a specialized hospital setting.
Björgvinsson T; Wetterneck CT; Powell DM; Chasson GS; Webb SA; Hart J; Heffelfinger S; Azzouz R; Entricht TL; Davidson JE; Stanley MA
J Psychiatr Pract; 2008 May; 14(3):137-45. PubMed ID: 18520782
[TBL] [Abstract][Full Text] [Related]
19. Obsessive-compulsive disorder. Diagnosis and management.
Ladouceur R; Freeston M; Gagnon F
Can Fam Physician; 1996 Jun; 42():1169-72, 1175-8. PubMed ID: 8704492
[TBL] [Abstract][Full Text] [Related]
20. Combination of CBT with fluoxetine works better for obsessive-compulsive disorder.
Giasuddin NA; Nahar JS; Morshed NM; Balhara YP
Asian J Psychiatr; 2012 Mar; 5(1):113. PubMed ID: 26878959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
